J M Bard
Overview
Explore the profile of J M Bard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
940
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rossignol E, Amiand M, Sorrieul J, Bard J, Bobin-Dubigeon C
J Pharmacol Toxicol Methods
. 2019 Nov;
101:106652.
PMID: 31734280
A wipe sampling procedure followed by a simple ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS) method was developed and validated for simultaneous quantification of six cytotoxic drugs: 5-fluorouracil (5FU),...
2.
El Roz A, Bard J, Huvelin J, Nazih H
Prostaglandins Leukot Essent Fatty Acids
. 2013 Feb;
88(4):265-72.
PMID: 23375583
Conjugated linoleic acids (CLA), naturally found in dairy products and ruminant meat, are positional and geometric isomers (trans: t or cis: c) of linoleic acid, and have been widely reported...
3.
Bobin-Dubigeon C, Amiand M, Herrenknecht C, Bard J
J Chromatogr B Analyt Technol Biomed Life Sci
. 2009 Jun;
877(24):2451-6.
PMID: 19560408
An improved liquid chromatography-mass spectrometry method for the determination of pemetrexed in human plasma was developed and validated using a simple quadrupole LC-MS and a new SPE cartridge (Plexa Bond...
4.
Lopez-Sall P, Bard J, Nazih H, Cisse A, Bobin-Dubigeon C, Sall N
Ann Biol Clin (Paris)
. 2008 Aug;
66(4):475-7.
PMID: 18725353
PPARs are supposed to be involved in pathogenesis of diabetes and its complications. According to some authors, L162V PPARalpha gene polymorphism would be associated to dyslipidemia susceptibility during diabetes, whereas...
5.
Bach-Ngohou K, Ouguerram K, Frenais R, Maugere P, Ripolles-Piquer B, Zair Y, et al.
J Pharmacol Exp Ther
. 2005 Jul;
315(1):363-9.
PMID: 16014756
Atorvastatin reduces both plasma cholesterol and triglyceride concentrations in patients with type 2 diabetes, but mechanisms underlying triglyceride decrease and the effect of atorvastatin on high density lipoprotein (HDL) still...
6.
Sebert S, Lecannu G, Kozlowski F, Siliart B, Bard J, Krempf M, et al.
Int J Obes (Lond)
. 2005 Jan;
29(3):324-33.
PMID: 15672115
Objective: To explore metabolic and cellular modifications induced during childhood obesity, in a novel animal model of obese mini-piglets. Design: A total of 10 four-month old Yucatan mini-pigs were followed...
7.
Ripolles Piquer B, Nazih H, Neunlist M, Huvelin J, Bard J
J Cell Biochem
. 2004 Mar;
91(4):786-95.
PMID: 14991770
The infection and inflammation process is associated with disturbances in lipid and lipoprotein metabolism. The apolipoprotein E (apo E) plays an important role in the lipoprotein metabolism and has been...
8.
Ferrer F, Nazih H, Zair Y, Krempf M, Bard J
Metabolism
. 2003 Dec;
52(12):1537-41.
PMID: 14669151
Plasma apolipoprotein AIV (apo AIV) level has been shown to be a good marker of triglyceride changes after a high-fat diet. However, the distribution of apo AIV between apo B-...
9.
Bach-Ngohou K, Ouguerram K, Nazih H, Maugere P, Ripolles-Piquer B, Zair Y, et al.
Int J Obes Relat Metab Disord
. 2002 Nov;
26(11):1451-8.
PMID: 12439646
Backgrounds And Aims: Insulin resistance related to obesity and diabetes is characterized by an increase in plasma TG-rich lipoprotein concentrations. Apolipoprotein (apo) E plays a crucial role in the metabolism...
10.
Bach-Ngohou K, Nazih H, Zair Y, Le Carrer D, Krempf M, Bard J
Int J Obes Relat Metab Disord
. 2002 Jan;
25(12):1752-8.
PMID: 11781754
Background: Obesity is frequently associated with an increase in the early inflammation marker C-reactive protein (CRP), insulin resistance and changes in lipoprotein metabolism. Increased CRP is known as an independent...